(Reuters) - NEW YORK, June 19 - U.S. stocks edged higher on
Tuesday as a favorable court ruling for the pharmaceutical
sector lifted shares of drugmakers, including Bristol-Myers
Squibb Co. , while a pullback in benchmark bond yields
tempered interest rate worries.
A disappointing profit from Best Buy Co. Inc. ,
however, limited a broader advance as its quarterly results
raised doubts about the U.S. economy's health and the outlook
for consumer spending.
Read more at Reuters.com Bonds News
Tuesday as a favorable court ruling for the pharmaceutical
sector lifted shares of drugmakers, including Bristol-Myers
Squibb Co. , while a pullback in benchmark bond yields
tempered interest rate worries.
A disappointing profit from Best Buy Co. Inc. ,
however, limited a broader advance as its quarterly results
raised doubts about the U.S. economy's health and the outlook
for consumer spending.
Read more at Reuters.com Bonds News
No comments:
Post a Comment